Product introduction

【Product Name】

COVID-19 Saliva Antigen Rapid Test




(1 test / Individual Packing)


【Storage And Stability】

Stored in a cool and dry place at 2~30℃, away from sunlight, moisture, heat and frozen condition. Kit contents are stable until the expiration date printed on the outer box. After opening the package, the kit is effective to be used in 1 hour under room temperature (25℃) and humidity (<60%); Buffer solution should be re-capped in time after use.

Expected use

        Tigsun COVID-19 Saliva Antigen Rapid Test is used for the qualitative detection of the COVID-19 antigen in human Saliva samples. The antigen detection kit detects the novel coronavirus N protein antigen, which can be detected in the early stage of viral infection and can be used as direct evidence of viral infection. It can be used as an auxiliary diagnostic index in clinical practice.

  • Detection principle

    Tigsun COVID-19 Antigen Rapid Test employs immunochromatography technology to detect the SARS-CoV-2 antigen in  human saliva specimens.

  • Product advantage

  • 1. Inexpensive, cost-efficency

  • 2. Simple to use, saliva samples, no instrument needed

  • 3. Non-invasive, fast, result in 15 minutes

  • 4. Accurate and reliable compared to molecular methods

  • Clinical symptoms

    • The main infection site of the SARS-CoV-2 is the lower respiratory tract. The incubation period of infection is variable. Common symptoms after infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and difficult breathing. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death.

  • Clinical symptoms

    1. Early supplementary screening of 2019-nCoV infection for clinics, hospitals and CDC.

    2. Screening for resumption of work in public institution and companies.

    3. Screening for suspected population.

    4. Screening for students back to school.



  • Tigsun COVID-19 Saliva Antigen Rapid Test is a lateral flow immunochromatographic assay intended for the rapid and qualitative detection of antigen from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human saliva samples from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.

  • Results are for the identification of SARS-CoV-2 antigen. The antigen is generally detectable in upper respiratory samples during the acute phase of infection.

  • The test is intended for self-use in adults. The application in adolescents and children should be carried out under the supervision of adults.

Screenshot 2021-06-02 at 10.11.02 PM.png

South Africa Mutant Study

HOME PAGE | Blesmedical Sdn Bhd

Screenshot 2021-12-07 at 3.11.58 PM.png



Screenshot 2021-06-05 at 2.34.21 PM.png
WhatsApp Image 2021-06-06 at 12.34.21 PM
Screenshot 2021-06-05 at 2.17.43 PM.png

TIGSUN Antigen Detail | Blesmedic Sdn Bhd